Clinton C. Mason

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia”.

SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-20-0168

N/A

1.8DataRank · unranked

63 citations

Anca Franzini, Anthony D. Pomicter, Brayden J. Halverson, Orlando Antelope, Clinton C. Mason +26 more

Coordinated inhibition of nuclear export and Bcr-Abl1 selectively targets chronic myeloid leukemia stem cells

Leukemia(2020)10.1038/s41375-020-0708-1

N/A

0DataRank · unranked

7 citations

Anthony D. Pomicter, Dongqing Yan, Larry Beaver, Anna M. Eiring, William L. Heaton +7 more

Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-20-0094

N/A

0DataRank · unranked

43 citations

Sasi Arunachalam, Tsewang Tashi, Monika J. Baker, Chad VanSant‐Webb, Amber Ferdig +7 more

The clear cell sarcoma functional genomic landscape

Journal of Clinical Investigation(2021)10.1172/jci146301

N/A

0DataRank · unranked

33 citations

Benjamin B. Ozenberger, Krystal Straessler, Jared J. Barrott, Li Li, Yanliang Wang +9 more

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism

Clinical and Translational Medicine(2022)10.1002/ctm2.1146

N/A

0DataRank · unranked

17 citations

Idaly M. Olivas, Alfonso E. Bencomo‐Alvarez, Andres J. Rubio, Christian Barreto‐Vargas, José López +25 more